This on-going interdisciplinary study of opiate narcotics seeks to identify, characterize and predict molecular determinants and modes of receptor binding which (1) lead to high affinity and selectivity in binding to different classes of receptors and (2) modulate relative efficacy, and hence exent of agonism and antagonism, within a given opiate family. To these ends we plan: A) Extensive structure activity studies of mu/kappa nonpeptide opiates. Theoretical investigation and measurement of receptor binding and efficacy for selected known analogs with varying degrees of mu- and kappa- selectivity to determine molecular indicators of high affinity, selectivity and relative efficacy at these receptors. Similar studies of new series of achiral beta-aminoamides related to the kappa-selective compound U-50,488 could yield new kappa-selective agonist and antagonists; B) Continued studies of opioid peptides and peptidomimetic, conformationall-restricted Tyr-Gly dipeptides to elucidate commonalities between peptides and nonpeptides and identify structural requirements for hgh affinity binding at the mu- or delta-receptor; C) Determination of conformational characteristics of beta endorphin analogs to test the hypothesis that alpha helical segments in the 14-31 region are required for high receptor affinity; D) Expansion of theoretical efforts to include more systematic conformational search strategies, computation of molecular electrostatic potentials, and evaluation of drug interactions with both site-specific and global receptor models; E) Expansion of our experimental efforts to provide better measures of activity with which to compare our theoretical results. These new efforts include: (1) measurement of biochemical consequences of opiate binding, such as stimulation of GTPase activity, (2) use of these results together with measured receptor affinities to determine relative efficacies of selected analogs, 3) a systematic comparison of different protocols for determining in vivo agonist and antagonist activities and 4) investigation of the relationship between efficacy and in vitro and in vivo end points for agonist and antagonist activities. These comprehensive interdisciplinary studies will substantially advance our understanding of the relationship between fundamental molecular properties, modes of receptor binding, receptor affinity and selectivity, efficacy and in vitro and in vivo agonist and antagonist activities of diverse families of opioids.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
2R01DA002622-09
Application #
3207454
Study Section
(SRCD)
Project Start
1980-03-01
Project End
1989-05-31
Budget Start
1988-09-01
Budget End
1989-05-31
Support Year
9
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Sri International
Department
Type
DUNS #
City
Menlo Park
State
CA
Country
United States
Zip Code
94025
Morgan, Judith K; Shaw, Daniel S; Olino, Thomas M et al. (2016) History of Depression and Frontostriatal Connectivity During Reward Processing in Late Adolescent Boys. J Clin Child Adolesc Psychol 45:59-68
Martin, Monica J; Conger, Rand D; Sitnick, Stephanie L et al. (2015) Reducing Risk for Substance Use by Economically Disadvantaged Young Men: Positive Family Environments and Pathways to Educational Attainment. Child Dev 86:1719-37
Morgan, Judith K; Shaw, Daniel S; Forbes, Erika E (2015) Fearfulness moderates the link between childhood social withdrawal and adolescent reward response. Soc Cogn Affect Neurosci 10:761-8
Morgan, Judith K; Shaw, Daniel S; Forbes, Erika E (2014) Maternal depression and warmth during childhood predict age 20 neural response to reward. J Am Acad Child Adolesc Psychiatry 53:108-117.e1
Filizola, M; Laakkonen, L; Loew, G H (1999) 3D modeling, ligand binding and activation studies of the cloned mouse delta, mu;and kappa opioid receptors. Protein Eng 12:927-42
Huang, P; Kim, S; Loew, G (1997) Development of a common 3D pharmacophore for delta-opioid recognition from peptides and non-peptides using a novel computer program. J Comput Aided Mol Des 11:21-8
Maguire, P A; Loew, G H (1996) Thermodynamics of ligand binding to the cloned delta-opioid receptor. Eur J Pharmacol 318:505-9
Alkorta, I; Loew, G H (1996) A 3D model of the delta opioid receptor and ligand-receptor complexes. Protein Eng 9:573-83
Chen, S W; Maguire, P A; Davies, M F et al. (1996) Evidence for mu1-opioid receptor involvement in fentanyl-mediated respiratory depression. Eur J Pharmacol 312:241-4
Chao, T M; Perez, J J; Loew, G H (1996) Characterization of the bioactive form of linear peptide antagonists at the omega-opioid receptor. Biopolymers 38:759-68

Showing the most recent 10 out of 27 publications